The JAK-STAT signaling pathway is differentially activated in CALR-positive compared with JAK2V617F-positive ET patients

被引：34
|
作者：
Lau, Winnie W. Y. [1 ,2 ,3 ]
Hannah, Rebecca [1 ,2 ,3 ]
Green, Anthony R. [1 ,2 ,3 ,4 ]
Goettgens, Bertie [1 ,2 ,3 ]
机构：
[1] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England
[2] Univ Cambridge, Wellcome Trust, Stem Cell Inst, Med Res Council, Cambridge, England
[3] Univ Cambridge, Dept Haematol, Cambridge, England
[4] Addenbrookes Hosp, Dept Haematol, Cambridge CB2 2QQ, England
来源：
BLOOD | 2015年 / 125卷 / 10期
基金：
英国惠康基金; 英国生物技术与生命科学研究理事会; 英国医学研究理事会;
关键词：
MYELOPROLIFERATIVE NEOPLASMS; ENRICHMENT ANALYSIS; MUTATIONS; CELLS;
D O I：
10.1182/blood-2014-12-618074
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1679 / 1681
页数：3
相关论文
共 50 条
  • [41] JAK2 V617F-positive essential thrombocythemia with subsequent development of immune thrombocytopenia A case report
    Oda, Yasuhiro
    Sato, Shuku
    Kanbe, Emiko
    Kamata, Wataru
    Okada, Satomi
    Tamai, Yotaro
    MEDICINE, 2019, 98 (44) : e17766
  • [42] JAK2 V617F positive splanchnic vein thrombosis has unique clinical features compared to WHO defined myeloproliferative neoplasms
    Atanze, S.
    Cutting, R.
    Went, R.
    Toth, P.
    Medlock, R.
    Francis, S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 : 47 - 47
  • [43] The G allele of the JAK2 rs10974944 SNP, part of JAK2 46/1 haplotype, is strongly associated with JAK2 V617F-positive myeloproliferative neoplasms
    Adrian P. Trifa
    Andrei Cucuianu
    Ljubomir Petrov
    Laura Urian
    Mariela S. Militaru
    Delia Dima
    Ioan V. Pop
    Radu A. Popp
    Annals of Hematology, 2010, 89 : 979 - 983
  • [44] The G allele of the JAK2 rs10974944 SNP, part of JAK2 46/1 haplotype, is strongly associated with JAK2 V617F-positive myeloproliferative neoplasms
    Trifa, Adrian P.
    Cucuianu, Andrei
    Petrov, Ljubomir
    Urian, Laura
    Militaru, Mariela S.
    Dima, Delia
    Pop, Ioan V.
    Popp, Radu A.
    ANNALS OF HEMATOLOGY, 2010, 89 (10) : 979 - 983
  • [45] Inhibition of USP9X Downregulates JAK2-V617F and Induces Apoptosis Synergistically with BH3 Mimetics Preferentially in Ruxolitinib-Persistent JAK2-V617F-Positive Leukemic Cells
    Akiyama, Hiroki
    Umezawa, Yoshihiro
    Watanabe, Daisuke
    Okada, Keigo
    Ishida, Shinya
    Nogami, Ayako
    Miura, Osamu
    CANCERS, 2020, 12 (02)
  • [46] Acute Transmural Myocardial Infarction by Coronary Embolism in a Patient with JAK2 V617F-Positive Essential Thrombocythemia
    Loria, Johannes Rotta Detto
    Rawluk, Justyna
    Krauss, Tobias
    Bode, Christoph
    Moser, Martin
    Helbing, Thomas
    HAMOSTASEOLOGIE, 2018, 38 (02): : 106 - 111
  • [47] JAK2V617F/STAT5 signaling pathway promotes cell proliferation through activation of Pituitary Tumor Transforming Gene 1 expression
    Shen, Xu-Liang
    Wei, Wu
    Xu, Hong-Liang
    Zhang, Mei-Xiang
    Qin, Xiao-Qi
    Shi, Wen-Zhi
    Jiang, Zhi-Ping
    Chen, Yi-Jian
    Chen, Fang-Ping
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 398 (04) : 707 - 712
  • [48] Combination treatment in vitro with Nutlin, a small-molecule antagonist of MDM2, and pegylated interferon-α 2a specifically targets JAK2V617F-positive polycythemia vera cells
    Lu, Min
    Wang, Xiaoli
    Li, Yan
    Tripodi, Joseph
    Mosoyan, Goar
    Mascarenhas, John
    Kremyanskaya, Marina
    Najfeld, Vesna
    Hoffman, Ronald
    BLOOD, 2012, 120 (15) : 3098 - 3105
  • [49] Clinical and laboratory relevance of JAK2 V617F and BCR-ABL co-existence in Philadelphia positive CML patients
    Ahmad, Nasir
    Qayum, Saima
    Jamee, Abid
    Ali, Asif
    Siraj, Sami
    Ali, Johar
    Yousafzai, Yasar Mehmood
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 34 (06) : 2289 - 2295
  • [50] Focal adhesion kinase inhibition decreases cell viability and induces apoptosis of JAK2 V617F positive cells
    Valente, Ana Carolina Menezes Mendonca
    de Farias, Gustavo Henrique Lima
    Bernardo, Ana Cristina Ribeiro
    Alves, Caio Cesar de Souza
    Pereira, Michelle Bueno de Moura
    Tognon-Ribeiro, Raquel
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 59
12345